Fan et al. [21] demonstrated that combining the CTLA-4 antibody with ICOS, an induced co-stimulator, may considerably increase the antitumor efficacy and immunosuppressive response in established mice melanoma and PCa models. Here, CTLA4 is linked to posterior cortical atrophy.